U.S. Asks Judge To Approve Seizure Of 'Pharma Bro' Assets

NEW YORK (CBSNewYork/AP) -- "Pharma Bro'' Martin Shkreli was back in court Friday for a hearing about whether he should forfeit millions of dollars in assets including a one-of-a-kind Wu-Tang Clan album as part of his conviction in a securities fraud scheme.

The brash former pharmaceutical CEO had a new look since since his bail was revoked in September: a scruffy beard that made his appearance less boyish. He also was wearing a loose-fitting jail uniform instead of street clothes.

Prosecutors argued in federal court in Brooklyn that Shkreli is on the hook for more than $7 million. Along with the Wu-Tang Clan "Once Upon a Time in Shaolin'' album that Shkreli has boasted he bought for $2 million, prosecutors said he should give up $5 million in cash in a brokerage account, his interest in a pharmaceutical company and other valuables including a Picasso painting.

The defense said the brash former pharmaceutical CEO owes nothing because in the end, his investors did not lose the money.

"This is a case where he did not benefit financially," defense attorney Benjamin Brafman said. "Well, I think there are all different types of punishment that the court has the discretion to impose."

Shkreli, 34, is perhaps best known for boosting the price of a life-saving drug and for trolling his critics on social media where he became known as "Pharma Bro.'' A jury convicted him in August of cheating investors in two failed hedge funds.

Shkreli was out on bail during his trial but was jailed afterward when a judge decided he had made veiled online threats against Democrat Hillary Clinton.

His sentencing is scheduled for March 9.

U.S. District Judge Kiyo Matsumoto will issue a ruling on the assets at a later date.

(© Copyright 2018 CBS Broadcasting Inc. All Rights Reserved. The Associated Press contributed to this report.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.